IP Library Granted Patent US 9,534,037
Granted Patent B2
US 9,534,037 · App. 13/565,046 · Granted Jan 3, 2017

Systems and methods to increase protein yield from recombinant manufacturing processes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,534,037
App. No.
13/565,046
Granted
Jan 3, 2017
Kind
B2
Abstract

Embodiments disclosed herein provide systems and methods that increase protein yield from recombinant manufacturing processes. The systems and methods treat used depth filters with bound proteins of interest as a stationary phase exchange resin to recapture bound protein of interest from the depth filter.

Claims (30)

1. A method of increasing the amount of a protein of interest available for recovery from a sample containing other components and following a first purification step of the sample comprising:

passing the sample through a depth filter;

creating a chromatographic column wherein the depth filter is treated as a stationary phase;

exposing the depth filter to an elution buffer wherein exposure to the elution buffer releases the protein of interest from the depth filter for subsequent recovery, wherein the protein of interest is Factor VIII, and wherein the elution buffer has a conductivity of at least 20 mS/cm.

2. A method of claim 1 further comprising: recovering the released Factor VIII from the elution buffer.

3. A method of claim 1 wherein the elution buffer is a salt elution buffer.

4. A method of claim 1 wherein the depth filter is positively-charged.

5. A method of claim 1 wherein the Factor VIII is recombinantly-produced.

6. A method of manufacturing and recovering a protein of interest comprising:

recombinantly producing a protein of interest using a host cell within a medium, wherein the protein of interest is Factor VIII;

filtering the medium using a depth filter;

creating a chromatographic column wherein the depth filter is treated as a stationary phase;

exposing the depth filter to an elution buffer having a conductivity of at least 20 mS/cm to release the Factor VIII from the depth filter;

recovering released Factor VIII from the elution buffer; and

recovering further Factor VIII from the sample passed through the depth filter.

7. A method of claim 6 wherein the elution buffer is a salt elution buffer.

8. A method of claim 6 wherein the filter is positively-charged.

9. A method of claim 6 further comprising:

combining the Factor VIII recovered from the elution buffer and the Factor VIII recovered from the sample passed through the depth filter into a pharmaceutical composition with pharmaceutically acceptable carriers.

10. A method of manufacturing a pharmaceutical composition comprising:

recombinantly producing a therapeutic protein of interest using a host cell within a medium, wherein the therapeutic protein is Factor VIII;

filtering the medium using a CUNO depth filter with a positive charge;

creating a chromatographic column where in the CUNO depth filter is treated as a stationary phase;

exposing the CUNO depth filter to a salt elution buffer with a conductivity of at least 20 mS/cm to release the Factor VIII from the CUNO depth filter;

recovering released Factor VIII from the salt elution buffer;

recovering further Factor VIII from the sample passed through the CUNO depth filter;

combining recovered Factor VIII with pharmaceutically acceptable carriers thereby forming the pharmaceutical composition.

11. A method of claim 10 wherein the salt elution buffer has a conductivity of at least 30 mS/cm.

12. A method of claim 10 wherein the salt elution buffer has a conductivity of at least 50 mS/cm.

13. A method of claim 10 wherein the Factor VIII is recombinantly-produced.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036368/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036369/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2012
From: ROY, SYLVAIN; VISSVESVARAN, GANESH
To: BAXTER INTERNATIONAL, INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 029189/0787 →